CLASS II Device recall · Reported 29 Sep 2021 · FDA Enforcement Report

cobas Sars-CoV-2 & Influenza A/B Test recalled

Roche Molecular Systems is recalling cobas Sars-CoV-2 & Influenza A/B Test for use on the cobas Liat System, distributed nationwide in the US. The recall was initiated on 4 Aug 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 10119Z
Quantity recalled211 kits (US); 3073 kits (OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2498-2021
FDA event ID
88600
Recalling firm
Roche Molecular Systems, Branchburg, NJ
Classification
Class II
Status
Terminated
Recall initiated
4 Aug 2021
FDA classified
21 Sep 2021
Reported
29 Sep 2021
Type
Voluntary: Firm initiated
Reason category
Other Reasons

Timeline

4 Aug 2021Recall initiated by company
21 Sep 2021Classified by FDA+48 days
29 Sep 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Customers have reported an increased number of false positive SARS-CoV-2 results.

Product as listed by the FDA

cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas Liat System, Catalog Number 09211101190

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of AR, CA, IL, IN, KS, ME, MI, MN, MO, NY, OR, TN, TX, WA, and WI. The countries of Canada, UK, Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Netherlands, Norway, Poland, Slovakia, and Spain.

Nationwide ArkansasCaliforniaIllinoisIndianaKansasMaineMichiganMinnesotaMissouriNew YorkOregonTennesseeTexasWashingtonWisconsin

Questions about this recall

Is cobas Sars-CoV-2 & Influenza A/B Test for use on the cobas Liat System recalled?

Yes. Roche Molecular Systems recalled cobas Sars-CoV-2 & Influenza A/B Test for use on the cobas Liat System on 4 Aug 2021. The recall is Class II and its status is Terminated. Recall number Z-2498-2021.

Why was it recalled?

Customers have reported an increased number of false positive SARS-CoV-2 results.

Which lots are affected?

Lot 10119Z

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of AR, CA, IL, IN, KS, ME, MI, MN, MO, NY, OR, TN, TX, WA, and WI. The countries of Canada, UK, Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Netherlands, Norway, Poland, Slovakia, and Spain.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Molecular Systems

All 42

Other Other Medical Devices recalls

All 13,778